The U.S. healthcare and pharmaceuticals industry is highly regulated and increasingly scrutinized by internal and external constituencies. To help its business leaders measure, manage, and mitigate the risks that matter most to their institutions, KPMG’s Healthcare & Pharmaceuticals practice offers its clients audit, advisory, and tax services grounded in deep experience across this industry.
For the latest insights on the Healthcare & Pharmaceutical Industry from KPMG, please visit the KPMG Healthcare & Pharmaceutical Institute.
KPMG’s Healthcare & Pharmaceuticals partners and professionals are trained, experienced, and focused on addressing needs in specific areas, including:
- Pharmaceuticals and biotechnology companies
- Providers: integrated healthcare systems, hospitals, academic medical centers, children’s hospitals, acute care systems, physician organizations, physician practice management companies, long-term care facilities, organizations serving seniors, post-acute care services, ambulatory care services, and disease management programs
- Payors: managed care organizations, indemnity insurers, government payors, and other medical insurance models
- Products: PBMs, medical device suppliers, distributors, and other industry intermediaries
|
|
|
 |
 |
